These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7725051)

  • 1. [Guidelines for the elaboration of programs for the primary prevention of cardiovascular diseases. The Working Group for Primary Cardiovascular Prevention].
    Banegas Banegas JR; Díez García MA; Sánchez RG; Gómez Esmorís L; Jiménez García-Pascual R; Juane Sánchez R; Juncadella García E; Martín Zurro A; Muñiz García J; Pérez Andrés C
    Rev Sanid Hig Publica (Madr); 1993; 67(1):5-22. PubMed ID: 7725051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of using different methods to assess cardiovascular risk in primary care.
    Fornasini M; Brotons C; Sellarès J; Martinez M; Galán ML; Sáenz I; da Pena JM
    Fam Pract; 2006 Feb; 23(1):28-33. PubMed ID: 16243952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
    Oriol-Zerbe C; Abholz HH
    Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
    Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG
    Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on regional variation in cardiovascular mortality within Europe.
    Müller-Nordhorn J; Binting S; Roll S; Willich SN
    Eur Heart J; 2008 May; 29(10):1316-26. PubMed ID: 18256043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualised multifactorial lifestyle intervention trial for high-risk cardiovascular patients in primary care.
    Ketola E; Mäkelä M; Klockars M
    Br J Gen Pract; 2001 Apr; 51(465):291-4. PubMed ID: 11458482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individuals' cardiovascular risk profile projected by family doctors and individuals' knowledge of cardiovascular risk factors: a challenge for primary prevention. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Celentano A; Palmieri V; Panico S; Russo C; Arezzi E; Pezzullo S; Minichiello S; Guillaro B; Brancati C; Piccinocchi G; Di Minno G
    Ital Heart J; 2005 Jul; 6(7):557-64. PubMed ID: 16274017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physical activity in basic and primary prevention of cardiovascular disease].
    Sobieszczańska M; Kałka D; Pilecki W; Adamus J
    Pol Merkur Lekarski; 2009 Jun; 26(156):659-64. PubMed ID: 19711738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The risk of suffering a cardiovascular disease in the making of decisions. From evidence to the clinic].
    Villar Alvarez F; Maiques Galán A; Franch Taix M; Banegas Banegas JR; Vilaseca Canals J
    Med Clin (Barc); 1999; 112 Suppl 1():67-73. PubMed ID: 10618802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for cardiovascular disease in Canada.
    Tanuseputro P; Manuel DG; Leung M; Nguyen K; Johansen H;
    Can J Cardiol; 2003 Oct; 19(11):1249-59. PubMed ID: 14571310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle modifications to prevent and control hypertension. 3. Recommendations on alcohol consumption. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Ashley MJ; Carruthers SG; Lacourcière Y; McKay DW
    CMAJ; 1999 May; 160(9 Suppl):S13-20. PubMed ID: 10333849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendations for the control of cholesterolemia in Spain].
    Villar Alvarez F; Mata López P; Plaza Pérez I; Pérez Jiménez F; Maiques Galán A; Casasnovas Lenguas JA; Banegas Banegas JR; Abadal LT; Rodríguez Artalejo F; Gil López E
    Rev Esp Salud Publica; 2000; 74(5-6):457-74. PubMed ID: 11217236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculation of individual cardiovascular risk in a primary prevention setting shows a high number of patients with a high risk score.
    Neuss M; Roser M; Kelle S; Girke F; Winbeck G; Stawowy P; Fleck E
    Z Kardiol; 2004 May; 93(5):413-5. PubMed ID: 15160278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases.
    Giampaoli S; Palmieri L; Mattiello A; Panico S
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):79-85. PubMed ID: 15871855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the evidence for health promotion: developing best practices for WISEWOMAN.
    Farris RP; Haney DM; Dunet DO
    J Womens Health (Larchmt); 2004 Jun; 13(5):634-43. PubMed ID: 15257855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India.
    Chow CK; Joshi R; Gottumukkala AK; Raju K; Raju R; Reddy S; Macmahon S; Neal B
    Am Heart J; 2009 Sep; 158(3):349-55. PubMed ID: 19699856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in premature deaths in Finland: successful long-term prevention of cardiovascular diseases.
    Puska P; Vartiainen E; Tuomilehto J; Salomaa V; Nissinen A
    Bull World Health Organ; 1998; 76(4):419-25. PubMed ID: 9803593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.